In addition to lowering the levels of blood glucose, as shown in Figure 1 , GLP-1RAs have also been shown to have a positive effect on multiple human tissues
And here's what that means clinically: GLP-1s require long-term use to sustain their benefits
Retatrutide is a 39-amino-acid synthetic peptide that simultaneously activates three receptors GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
The paper explores the science at the intersection of metabolic hormones and precision nutrition and multi-target therapies, like tirzepatide and retatrutide
D., Alfonso-Cristancho, R., Conner, C., Hammer, M., & Blonde, L
Beyond genetics, consistency matters mostskipping doses or irregular injection timing slows the medication's cumulative effect